Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitor
US10738310B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 23, 2015 |
| Grant date | Aug 11, 2020 |
| Priority date | — |
| Expiry date | Jan 17, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4716
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This present invention compositions and methods of treating cancer and methods of accessing/monitoring the responsiveness of a cancer cell to a therapeutic compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.